Assessment of CEA, CA-125, and CA19-9 as adjuncts in non-small cell lung cancer management
MedicalXpress,
Conventional tumor markers may serve as adjuncts in non-small cell lung cancer (NSCLC) management.
Evaluation of serum tumor markers as adjuncts in NSCLC management
The Medical News,
A new research paper was published in Oncotarget's Volume 15 on June 13, 2024, entitled, "Assessment of serum tumor markers CEA…
Assessment of CEA, CA-125, and CA19-9 as adjuncts in non-small cell lung cancer management On June 13, 2024, a new research paper was published in entitled, “Assessment of serum tumor markers CEA, CA-125, and CA19-9 as adjuncts in non-small cell lung canc
EurekAlert!,
image: Assessment of serum tumor markers CEA, CA-125, and CA19-9 as adjuncts in non-small cell lung cancer management view more…
Evaluating CEA, CA-125, CA19-9 in Managing Non-Small Cell Lung Cancer
Mirage News,
"[...] these inexpensive, widely available tests with rapid turnaround times and relatively short half-lives (CEA, CA-125, and…
Assessment of CEA, CA-125, and CA19-9 as Adjuncts in Non-small Cell Lung Cancer Management
Oncotarget Press Releases,
[...] these inexpensive, widely available tests with rapid turnaround times and relatively short half-lives (CEA, CA-125, and…